Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
NCT00001158 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2008-03-05
Summary
The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization with antigens will be utilized.
Conditions
- Immunologic Deficiency Syndromes
- Neoplasms
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1977-04-30
- Completion
- 2000-03-31
Countries
- United States
Study Locations
More Related Trials
-
Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy
NCT06089967 ·Status: COMPLETED
-
Vaccine-induced Immunity in Immunocompromised Patients
NCT06612515 ·Status: RECRUITING
-
Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy
NCT04283539 ·Status: RECRUITING
-
T Cell Response in Hypersensitivity Syndrome
NCT00213447 ·Status: COMPLETED
-
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
NCT05995821 ·Status: RECRUITING
-
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
NCT00001336 ·Status: COMPLETED
-
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
NCT04242095 ·Status: RECRUITING
-
Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
NCT00430053 ·Status: COMPLETED
-
Effects of Systemically Administered Hydrocortisone on the Immune System in Healthy Volunteers
NCT01281995 ·Status: COMPLETED
-
Study of the Immune Response After Vaccination in Multiple Myeloma Patients
NCT02294487 ·Status: COMPLETED
-
Immune Profiling for Cancer Immunotherapy Response
NCT06116032 ·Status: RECRUITING
-
Immunity to Infection in Healthy Participants and Participants With Cancer
NCT05787964 ·Status: ACTIVE_NOT_RECRUITING
-
Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis
NCT06040918 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection
NCT04362865 ·Status: COMPLETED
-
Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals
NCT04871165 ·Status: UNKNOWN
-
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer
NCT00823524 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immune Cell Response to Stimuli
NCT00397280 ·Status: RECRUITING
-
Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint Inhibitors
NCT03989050 ·Status: WITHDRAWN
-
Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus
NCT00001985 ·Status: COMPLETED
-
Safety and Efficacy Study of Donor Natural Killer Cells Given After Haploidentical Hematopoietic Cell Transplantation
NCT01795378 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer
NCT00057915 ·Status: COMPLETED ·Phase: PHASE1
-
Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies
NCT01915992 ·Status: UNKNOWN ·Phase: NA
-
Understanding COVID-19 Vaccine Immunity in Tissue and Blood
NCT05682625 ·Status: WITHDRAWN
-
Sequencing T-cells in Type I Diabetes Mellitus
NCT02040337 ·Status: COMPLETED
-
Immune Response to the COVID-19 Vaccine
NCT04936997 ·Status: COMPLETED ·Phase: EARLY_PHASE1